Urelumab (Anti-TNFRSF9 / 4-1BB / CD137)
Urelumab (Anti-TNFRSF9 / 4-1BB / CD137) is a fully human agonistic monoclonal antibody targeting the CD137 receptor with potential immunostimulatory and antineoplastic activities. MW : 146.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2321 |
Sku # | A2321-1mg*25 |
Pricing | 1mg*25, $5970.00 |